In this article written for Thomson Reuters Westlaw, partner Susan Feigin Harris details the effect of the March 13 waivers of certain regulatory requirements by the US Department of Health and Human Services in response to the coronavirus (COVID-19) crisis and the implications of the guidance for healthcare providers.